The facility will manufacture filtration systems for biotechnology, pharmaceuticals and blood banking. Pall anticipates double-digit growth in sales for these products over the next three to five years. The Hauppauge plant will double Pall's production capacity.
Pall Corporation specializes in filtration, separation and purification for clients in the biotechnology, pharmaceutical, semiconductor, municipal drinking water, aerospace, blood banking and transfusion industries.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
